Itron
ITRI
85.58
-2.81
-3.18%
Itron
US · ITRI
#2311 by market cap
Listed 1970
85.58
-2.81
-3.18%
Live - 5344 symbols - heartbeat 381s ago
· 2026-10-08 06:06
Pre-market
85.77
+0.22%
After-hours
85.58
0.00%
Overnight
85.58
0.00%
- Market cap
- 3.75B
- P/E (TTM)i
- 14.31
- P/Bi
- 2.32
- EPSi
- 6.50
- Div yieldi
- 0.00%
- 52W posi
- 12%
Reader sentiment
Are you bullish or bearish on ITRI?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.35, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -3.02% YoY
Margins
- Gross margin
- 37.69%
- Operating margin
- 13.27%
- Net margin
- 12.72%
Key ratios & quality
- Enterprise valuei
- 3.98B
- Altman Z-Scorei
- 2.35
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.38B | 2.50B | 2.17B | 1.98B | 1.80B | 2.17B | 2.44B | 2.37B |
| Gross profit | 730.32M | 752.32M | 602.17M | 573.17M | 522.19M | 713.91M | 839.32M | 892.12M |
| Selling & admin expenses | 423.21M | 346.87M | 276.92M | 300.52M | 290.45M | 312.78M | 339.07M | 352.97M |
| Research & development | 207.91M | 202.20M | 194.10M | 197.24M | 185.10M | 208.69M | 215.03M | 207.04M |
| Operating profit | 27.49M | 138.96M | 86.44M | 39.61M | 20.92M | 173.52M | 267.39M | 314.08M |
| Pretax profit | -109.15M | 73.03M | -56.64M | -123.81M | -15.74M | 127.39M | 284.53M | 342.27M |
| Tax | -12.57M | 20.62M | 238.00K | -45.51M | -6.20M | 29.07M | 43.41M | 38.93M |
| Net profit | -96.58M | 52.42M | -56.88M | -78.30M | -9.55M | 98.32M | 241.12M | 303.34M |
| Basic EPS | -3 | 1 | -1 | -2 | 0 | 2 | 5 | 7 |
| Diluted EPS | -2.53 | 1.23 | -1.44 | -1.83 | -0.22 | 2.11 | 5.18 | 6.50 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 607.15M | 606.76M | 581.63M | 571.66M | 586.98M | 562.90M |
| Gross profit | 217.22M | 223.62M | 219.55M | 231.74M | 236.32M | 230.64M |
| Selling & admin expenses | 86.91M | 87.62M | 83.14M | 95.30M | 105.36M | 89.72M |
| Research & development | 50.09M | 53.81M | 50.03M | 53.11M | 55.00M | 56.14M |
| Operating profit | 75.74M | 77.65M | 81.97M | 78.72M | 67.79M | 76.30M |
| Pretax profit | 82.28M | 83.48M | 90.70M | 85.81M | 67.20M | 80.21M |
| Tax | 16.93M | 14.73M | 24.48M | -17.21M | 13.61M | 26.73M |
| Net profit | 65.35M | 68.75M | 66.22M | 103.01M | 53.59M | 53.47M |
| Basic EPS | 1 | 2 | 1 | 2 | 1 | 1 |
| Diluted EPS | 1.42 | 1.47 | 1.41 | 2.21 | 1.18 | 1.19 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 896.14M | 997.25M | 930.26M | 749.93M | 829.58M | 1.05B | 1.82B | 1.82B |
| Cash & ST investments | 120.22M | 149.90M | 206.93M | 162.58M | 202.01M | 302.05M | 1.05B | 1.02B |
| Inventory | 220.67M | 227.90M | 182.38M | 165.80M | 228.70M | 283.69M | 270.73M | 242.89M |
| Total assets | 2.61B | 2.71B | 2.61B | 2.39B | 2.38B | 2.60B | 3.41B | 3.72B |
| Total current liabilities | 652.71M | 671.39M | 549.90M | 501.34M | 498.57M | 537.24M | 528.27M | 1.01B |
| Short-term debt | 28.44M | -- | 18.36M | -- | -- | -- | -- | 459.52M |
| Long-term debt | 988.19M | 932.48M | 902.58M | 450.23M | 452.53M | 454.83M | 1.24B | 788.81M |
| Total liabilities | 1,874,934,000.00 | 1,907,026,000.00 | 1,766,750,000.00 | 1,251,031,000.00 | 1,186,522,000.00 | 1,272,832,000.00 | 1,996,195,000.00 | 1,982,511,000.00 |
| Total equity | 734.05M | 800.82M | 840.27M | 1.14B | 1.19B | 1.33B | 1.41B | 1.74B |
| Retained earnings | -425.40M | -376.39M | -434.35M | -515.60M | -525.33M | -428.41M | -189.30M | 111.75M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.90B | 1.99B | 2.14B | 1.82B | 1.52B | 1.55B |
| Cash & ST investments | 1.12B | 1.22B | 1.33B | 1.02B | 712.85M | 745.23M |
| Inventory | 281.88M | 283.30M | 255.28M | 242.89M | 239.89M | 258.73M |
| Total assets | 3.50B | 3.62B | 3.71B | 3.72B | 3.98B | 3.99B |
| Total current liabilities | 983.42M | 973.06M | 987.37M | 1.01B | 573.62M | 564.23M |
| Short-term debt | 457.75M | 458.33M | 458.93M | 459.52M | -- | -- |
| Long-term debt | 786.14M | 787.02M | 787.91M | 788.81M | 1.57B | 1.58B |
| Total liabilities | 1,994,063,000.00 | 1,989,344,000.00 | 1,997,343,000.00 | 1,982,511,000.00 | 2,349,256,000.00 | 2,355,417,000.00 |
| Total equity | 1.51B | 1.63B | 1.71B | 1.74B | 1.63B | 1.64B |
| Retained earnings | -123.83M | -55.49M | 10.12M | 111.75M | 165.21M | 218.48M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 109.76M | 172.84M | 109.51M | 154.79M | 24.50M | 124.97M | 238.18M | 405.95M |
| Depreciation & amortization | 122.50M | 114.40M | 97.29M | 84.15M | 66.76M | 55.76M | 56.28M | 49.52M |
| Free cash flow | 49.80M | 112.09M | 63.31M | 120.11M | 4.75M | 98.09M | 207.61M | 383.06M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 9.17M | -610.00K | 8.89M | 386.47M | -13.52M | 3.67M | -91.68M | -92.68M |
| Ending cash balance | 122.33M | 149.90M | 206.93M | 162.58M | 202.01M | 302.05M | 1.05B | 1.02B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 72.12M | 96.69M | 117.83M | 119.32M | 85.50M | 88.09M |
| Depreciation & amortization | 12.07M | 12.11M | 12.04M | 13.30M | 18.54M | 18.63M |
| Free cash flow | 67.48M | 90.67M | 113.41M | 111.51M | 78.97M | 81.49M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 2.20M | 3.24M | 896.00K | -99.01M | -99.32M | -50.94M |
| Ending cash balance | 1.12B | 1.22B | 1.33B | 1.02B | 712.85M | 745.23M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -13.24 | 6.58 | -7.28 | -8.41 | -0.85 | 7.82 | 17.70 | 19.38 |
| ROA %i | -4.21 | 1.84 | -2.18 | -3.25 | -0.41 | 3.89 | 7.95 | 8.45 |
| ROIC %i | -3.19 | 4.91 | -1.56 | -3.77 | -0.44 | 5.55 | 10.00 | 9.11 |
| 5-year avg ROE %i | -0.23 | 1.71 | -0.14 | -2.85 | -4.64 | -0.43 | 1.80 | 7.13 |
| EBIT margin %i | -2.14 | 5.01 | -0.58 | -4.80 | -0.50 | 6.24 | 12.29 | 15.41 |
| FCF / sales %i | 2.10 | 4.48 | 2.91 | 6.06 | 0.26 | 4.51 | 8.51 | 16.18 |
| Current ratioi | 1.37 | 1.49 | 1.69 | 1.50 | 1.66 | 1.95 | 3.44 | 1.80 |
| Quick ratioi | 0.85 | 0.93 | 1.05 | 0.92 | 0.97 | 1.13 | 2.65 | 1.37 |
| Debt / assetsi | 38.97 | 36.98 | 37.89 | 21.20 | 20.89 | 18.72 | 37.20 | 34.08 |
| LT debt / equityi | 138.66 | 128.96 | 118.72 | 45.48 | 42.53 | 37.19 | 91.17 | 47.09 |
| Interest coveragei | -0.88 | 2.39 | -0.29 | -3.32 | -1.34 | 16.26 | 19.50 | 16.25 |
| Revenue CAGR (3Y) %i | 8.05 | 7.52 | 2.50 | -5.87 | -10.48 | 0.00 | 7.20 | 9.65 |
| Net income CAGR (3Y) %i | -- | 15.54 | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | 19.16 | 15.74 | -23.58 | 34.10 | -65.13 | 15.71 | 20.01 | 331.95 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 17.73 | 18.92 | 16.93 | 19.38 | 18.67 | 16.97 |
| ROA %i | 8.18 | 7.81 | 7.28 | 8.45 | 7.73 | 7.19 |
| ROIC %i | 9.21 | 8.43 | 7.81 | 9.11 | 9.86 | 9.30 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 13.12 | 13.94 | 14.48 | 15.41 | 14.91 | 15.05 |
| FCF / sales %i | 9.86 | 11.75 | 14.19 | 16.18 | 16.81 | 16.73 |
| Current ratioi | 1.93 | 2.04 | 2.17 | 1.80 | 2.66 | 2.75 |
| Quick ratioi | 1.49 | 1.61 | 1.72 | 1.37 | 1.93 | 1.94 |
| Debt / assetsi | 36.14 | 35.11 | 34.22 | 34.08 | 40.27 | 40.10 |
| LT debt / equityi | 54.32 | 50.46 | 47.89 | 47.09 | 99.68 | 99.08 |
| Interest coveragei | 16.81 | 15.17 | 15.52 | 16.25 | 15.43 | 15.21 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Networked Solutions is the largest reported line at 60.27% of revenue, across 4 reported segments.
- Device Solutions follows at 19.80%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Networked Solutions60.27%
Device Solutions19.80%
Outcomes17.13%
Resiliency Solutions2.81%
Quote time 2026-10-08 06:06:54 · For reference only, not investment advice and not tailored to your situation.